160 Participants Needed

Computer-Based Cognitive Behavioral Therapy for Chronic Pain in Opioid Treatment

(IMPACT Trial)

Recruiting at 2 trial locations
T
Overseen ByTBN
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Yale University
Must be taking: Methadone, Buprenorphine
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The investigators plan to develop and pilot test an integrated, web-based cognitive behavioral approach and then conduct a randomized clinical trial evaluating its efficacy relative to standard care in a large and diverse sample of individuals with chronic pain treated with buprenorphine or methadone. The new program will retain key components of Dr. Carroll's computer-based training for cognitive-behavioral therapy (CBT4CBT), including its emphasis on teaching cognitive and behavioral coping skills in an engaging way and focus on the 5 A's of MAT (Adherence, Attendance, Abstinence, Alternate Activities and Accessing support); it will add components from Dr. Heapy's COPES (Cooperative Pain Education and Self-Management) intervention (self-management of chronic pain, with daily surveys via text that monitor pain intensity and interference, physical activity, and skills practice) and modify existing CBT4CBT modules to address the complex interplay between pain and drug use in this population, emphasizing the development of generalizable skills. A randomized clinical trial evaluating CBT4CBT-COPES will be conducted in a diverse sample 160 of individuals enrolled in agonist treatment (methadone or buprenorphine) who have chronic pain, in a 3-month randomized clinical trial with a 6-month follow-up, comparing it to standard treatment alone. The primary retention outcome will be adherence with agonist treatment; the primary pain outcome will be the PROMIS 6-item Pain Interference Short Form.

Do I have to stop taking my current medications to join the trial?

The trial does not specify if you need to stop taking your current medications. However, participants must be enrolled in methadone or buprenorphine treatment, so you should continue those medications.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, it does require participants to be on methadone or buprenorphine treatment.

What data supports the idea that Computer-Based Cognitive Behavioral Therapy for Chronic Pain in Opioid Treatment is an effective treatment?

The available research shows that Computer-Based Cognitive Behavioral Therapy (CBT) for chronic pain is effective. Studies indicate that CBT helps people manage chronic pain and improve their outcomes. For example, the COPES trial found that technology-assisted CBT is as effective as in-person therapy for chronic back pain. Additionally, web-based CBT has been shown to increase access to pain management and is comparable in effectiveness to face-to-face therapy. These findings suggest that computer-based CBT is a promising alternative for those who cannot access traditional therapy.12345

What data supports the effectiveness of the treatment CBT4CBT COPES for chronic pain in opioid treatment?

Cognitive behavioral therapy (CBT) has been shown to help manage chronic pain and improve outcomes, and technology-assisted delivery of CBT can maintain its effectiveness while improving access. Studies have found that web-based CBT can be as effective as in-person therapy for chronic pain management.12345

What safety data exists for computer-based CBT for chronic pain?

The research indicates that cognitive behavioral therapy for chronic pain (CBT-CP) is a safe and effective alternative to opioid analgesics. Multiple studies have shown that CBT-CP is an evidence-based treatment that improves pain management and outcomes. Technology-assisted delivery of CBT, such as through interactive voice response or web-based platforms, can maintain efficacy while improving access, although specific safety data for these formats is not detailed in the provided abstracts.12346

Is computer-based cognitive behavioral therapy for chronic pain safe for humans?

Cognitive behavioral therapy for chronic pain (CBT-CP), including its computer-based versions, is considered safe for humans and is an effective alternative to opioid pain medications.12346

Is the treatment CBT4CBT COPES a promising treatment for chronic pain in people using opioids?

Yes, CBT4CBT COPES is a promising treatment for chronic pain. It is based on cognitive-behavioral therapy, which has been shown to be effective in reducing pain and related problems. This type of therapy can be delivered through technology, making it more accessible to people who might not have easy access to therapists. It is a safe alternative to using opioids for pain management.23678

How is the CBT4CBT COPES treatment different from other treatments for chronic pain?

CBT4CBT COPES is unique because it is a computer-based cognitive behavioral therapy specifically designed for chronic pain in patients undergoing opioid treatment, making it more accessible and potentially more convenient than traditional in-person therapy sessions.23678

Research Team

AH

Alicia Heapy, PhD

Principal Investigator

Yale University

Eligibility Criteria

Adults over 18 with opioid use disorder (OUD) who are on methadone or buprenorphine treatment and have chronic pain. They must be able to walk a block, speak English at a basic level, and not have severe health issues or untreated mental disorders that could interfere with the study.

Inclusion Criteria

You meet the official guidelines for opioid use disorder (OUD) according to the DSM-5.
I am currently in a methadone or buprenorphine program at Liberation.
I am 18 years old or older.
See 3 more

Exclusion Criteria

Inability to read, write, and speak English at a third grade level (for reading informed consent)
I am scheduled for surgery to manage my pain.
Pending legal action or planned relocation that makes it unlikely they would be able to complete the study
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Treatment

Participants receive CBT4CBT-COPES or standard care for 12 weeks, with weekly meetings and assessments

12 weeks
12 visits (in-person or virtual)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with follow-up interviews at 1, 3, and 6 months post-treatment

6 months
3 visits (in-person or virtual)

Treatment Details

Interventions

  • CBT4CBT COPES
Trial OverviewThe trial is testing an integrated web-based program combining cognitive-behavioral therapy (CBT4CBT) and Cooperative Pain Education Self-Management (COPES). It aims to improve adherence to medication-assisted treatment for OUD and manage chronic pain better than standard care alone.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: CBT4CBT-CopesExperimental Treatment1 Intervention
Individuals will receive standard agonist treatment plus access to the CBT4CBT-COPES website plus daily texts with a link to a survey.
Group II: Standard care treatment as usual (TAU)Active Control1 Intervention
Individuals will receive buprenorphine or methadone in addition to regular individual or group sessions as offered by the clinic

CBT4CBT COPES is already approved in United States for the following indications:

๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as CBT4CBT COPES for:
  • Chronic pain management in individuals treated with buprenorphine or methadone

Find a Clinic Near You

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials
1,963
Recruited
3,046,000+

National Center for Complementary and Integrative Health (NCCIH)

Collaborator

Trials
886
Recruited
677,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

Findings from Research

The COPES trial demonstrated that interactive voice response-based cognitive behavioral therapy (IVR-CBT) is as effective as in-person CBT for managing chronic back pain, with similar reductions in pain intensity after 3 months.
IVR-CBT also showed lower dropout rates, suggesting it may be a more accessible and convenient option for patients, enhancing their ability to engage in treatment compared to traditional in-person therapy.
Interactive Voice Response-Based Self-management for Chronic Back Pain: The COPES Noninferiority Randomized Trial.Heapy, AA., Higgins, DM., Goulet, JL., et al.[2019]
Cognitive-behavioral therapy (CBT) is an effective first-line treatment for chronic pain, supported by numerous randomized controlled trials showing improvements in pain and related issues across various chronic pain syndromes.
Recent innovations in CBT delivery, such as web-based and telephone formats, have expanded its accessibility and effectiveness for diverse populations, including children and older adults, indicating a promising direction for future treatment approaches.
Cognitive-behavioral therapy for individuals with chronic pain: efficacy, innovations, and directions for research.Ehde, DM., Dillworth, TM., Turner, JA.[2022]
In a study involving 290 veterans with chronic back pain, 54% declined to participate in cognitive behavioral therapy for chronic pain (CBT-CP) due to lack of interest, indicating low overall enrollment rates.
Patients not receiving opioid prescriptions were more likely to enroll in the trial, suggesting that those on opioids, who may benefit from alternative pain management strategies, are underrepresented in CBT-CP programs.
Predictors of Participation in a Nonpharmacological Intervention for Chronic Back Pain.Higgins, DM., LaChappelle, KM., Serowik, KL., et al.[2019]

References

Interactive Voice Response-Based Self-management for Chronic Back Pain: The COPES Noninferiority Randomized Trial. [2019]
Cognitive-behavioral therapy for individuals with chronic pain: efficacy, innovations, and directions for research. [2022]
Predictors of Participation in a Nonpharmacological Intervention for Chronic Back Pain. [2019]
Cooperative pain education and self-management (COPES): study design and protocol of a randomized non-inferiority trial of an interactive voice response-based self-management intervention for chronic low back pain. [2022]
Nurse-Supported Web-Based Cognitive Behavioral Therapy for Chronic Musculoskeletal Pain: A Randomized Controlled Trial. [2023]
Patient-Centered Pain Care Using Artificial Intelligence and Mobile Health Tools: A Randomized Comparative Effectiveness Trial. [2023]
A Primary Care-Based Cognitive Behavioral Therapy Intervention for Long-Term Opioid Users With Chronic Pain : A Randomized Pragmatic Trial. [2022]
Physical therapists' use of cognitive-behavioral therapy for older adults with chronic pain: a nationwide survey. [2021]